Latest Update on Outer Membrane Vesicles and Their Role in Horizontal Gene Transfer: A Mini-Review.

Gram-negative bacteria extracellular vesicles horizontal gene transfer outer membrane vesicles vesiduction

Journal

Membranes
ISSN: 2077-0375
Titre abrégé: Membranes (Basel)
Pays: Switzerland
ID NLM: 101577807

Informations de publication

Date de publication:
26 Oct 2023
Historique:
received: 20 09 2023
revised: 23 10 2023
accepted: 24 10 2023
medline: 24 11 2023
pubmed: 24 11 2023
entrez: 24 11 2023
Statut: epublish

Résumé

Outer membrane vesicles (OMVs) are spherical, lipid-based nano-structures, which are released by Gram-negative bacteria in both in vitro and in vivo conditions. The size and composition of OMVs depend on not only the producer bacterial species but also cells belonging to the same strain. The mechanism of vesicles' biogenesis has a key role in determining their cargo and the pattern of macromolecules exposed on their surface. Thus, the content of proteins, lipids, nucleic acids, and other biomolecules defines the properties of OMVs and their beneficial or harmful effects on human health. Many studies have provided evidence that OMVs can be involved in a plethora of biological processes, including cell-to-cell communication and bacteria-host interactions. Moreover, there is a growing body of literature supporting their role in horizontal gene transfer (HGT). During this process, OMVs can facilitate the spreading of genes involved in metabolic pathways, virulence, and antibiotic resistance, guaranteeing bacterial proliferation and survival. For this reason, a deeper understanding of this new mechanism of genetic transfer could improve the development of more efficient strategies to counteract infections sustained by Gram-negative bacteria. In line with this, the main aim of this mini-review is to summarize the latest evidence concerning the involvement of OMVs in HGT.

Identifiants

pubmed: 37999346
pii: membranes13110860
doi: 10.3390/membranes13110860
pmc: PMC10673008
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Front Microbiol. 2015 Dec 16;6:1369
pubmed: 26733944
mBio. 2021 Jun 29;12(3):e0053421
pubmed: 34076466
J Vis Exp. 2021 Mar 28;(169):
pubmed: 33843938
Front Immunol. 2018 Jul 02;9:1466
pubmed: 30013553
mSphere. 2020 Nov 25;5(6):
pubmed: 33239369
Nat Rev Genet. 2015 Aug;16(8):472-82
pubmed: 26184597
Pathogens. 2022 Apr 18;11(4):
pubmed: 35456156
Appl Environ Microbiol. 2000 Oct;66(10):4414-20
pubmed: 11010892
Front Cell Infect Microbiol. 2018 Jul 04;8:230
pubmed: 30023354
Front Immunol. 2021 Sep 15;12:730434
pubmed: 34603306
Nat Commun. 2023 Jan 28;14(1):464
pubmed: 36709333
Methods Mol Biol. 2017;1660:221-232
pubmed: 28828660
Front Microbiol. 2020 Feb 27;11:290
pubmed: 32174900
Microorganisms. 2023 Aug 15;11(8):
pubmed: 37630648
FEMS Microbiol Rev. 2021 Mar 16;45(2):
pubmed: 32926132
Proc Natl Acad Sci U S A. 1983 Nov;80(22):6927-31
pubmed: 6316334
EMBO J. 2021 Nov 2;40(21):e108174
pubmed: 34636061
Sci Rep. 2017 Aug 18;7(1):8813
pubmed: 28821711
Immunohorizons. 2020 Aug 20;4(8):508-519
pubmed: 32819967
J Fungi (Basel). 2018 Feb 20;4(1):
pubmed: 29461490
J Bacteriol. 1973 Nov;116(2):1029-53
pubmed: 4200845
Adv Drug Deliv Rev. 2020;159:308-321
pubmed: 32151658
Transbound Emerg Dis. 2022 Sep;69(5):e2661-e2676
pubmed: 35679514
Int J Mol Sci. 2021 Oct 27;22(21):
pubmed: 34769015
Curr Res Microb Sci. 2020 Sep 17;2:100009
pubmed: 34841303
Proteomics. 2009 Dec;9(24):5425-36
pubmed: 19834908
Acta Biomater. 2022 Mar 1;140:102-115
pubmed: 34896632
ACS Omega. 2019 Jun 19;4(6):10687-10694
pubmed: 31460166
Sci Rep. 2022 Dec 24;12(1):22324
pubmed: 36566282
Sci Rep. 2017 Aug 1;7(1):7072
pubmed: 28765539
Biodegradation. 2021 Aug;32(4):435-448
pubmed: 33886019
Front Cell Infect Microbiol. 2021 Jan 28;10:585917
pubmed: 33585266
ACS Omega. 2021 Dec 28;7(1):240-258
pubmed: 35036696
Antimicrob Agents Chemother. 2023 May 17;67(5):e0144422
pubmed: 37052502
Microb Biotechnol. 2020 Jul;13(4):1162-1178
pubmed: 32348028
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
NPJ Vaccines. 2019 Jul 8;4:24
pubmed: 31312527
Adv Drug Deliv Rev. 2021 Jun;173:125-140
pubmed: 33774113
Front Microbiol. 2020 Mar 24;11:432
pubmed: 32265873
Nat Rev Microbiol. 2022 Apr;20(4):236-248
pubmed: 34732874
Biomed Res Int. 2021 Mar 24;2021:1490732
pubmed: 33834062
Proteomics. 2023 May;23(10):e2200464
pubmed: 36781972
Microbiol Spectr. 2023 Mar 22;:e0517922
pubmed: 36946779
J Bacteriol. 1989 May;171(5):2499-505
pubmed: 2496108
J Antimicrob Chemother. 2020 Sep 1;75(9):2442-2451
pubmed: 32562546
Nat Rev Microbiol. 2023 Jul;21(7):415-430
pubmed: 36932221
Microbiol Spectr. 2022 Oct 26;10(5):e0137922
pubmed: 36000914
Nat Rev Microbiol. 2019 Jan;17(1):13-24
pubmed: 30397270
Int J Mol Sci. 2021 Aug 13;22(16):
pubmed: 34445438
Microbiol Spectr. 2022 Oct 26;10(5):e0181922
pubmed: 36040198
Emerg Microbes Infect. 2022 Dec;11(1):1281-1292
pubmed: 35437096
Sens Actuators Rep. 2021 Nov;3:
pubmed: 35098157
Front Microbiol. 2020 Dec 09;11:600221
pubmed: 33362747
Pharmaceutics. 2023 Feb 04;15(2):
pubmed: 36839844
Microbiology (Reading). 2021 Apr;167(4):
pubmed: 33871329
J Mol Biol. 2020 Feb 14;432(4):1251-1264
pubmed: 31931013
Infect Immun. 1987 Mar;55(3):609-15
pubmed: 3818086
Int J Mol Sci. 2021 Nov 27;22(23):
pubmed: 34884635
Pathog Dis. 2022 Aug 24;80(1):
pubmed: 35927587
Antimicrob Agents Chemother. 2011 Jul;55(7):3084-90
pubmed: 21518847
Curr Med Sci. 2023 Feb;43(1):80-85
pubmed: 36602673
Front Microbiol. 2021 Nov 29;12:747606
pubmed: 34912309
Front Microbiol. 2020 Jan 17;10:3026
pubmed: 32038523
Virulence. 2020 Dec;11(1):995-1005
pubmed: 32799627
J Enzyme Inhib Med Chem. 2019 Dec;34(1):189-195
pubmed: 30734607
Front Microbiol. 2021 Feb 25;12:639582
pubmed: 33717034
Front Microbiol. 2021 Oct 08;12:713669
pubmed: 34690958
Front Microbiol. 2021 Aug 16;12:715802
pubmed: 34484157
Int J Mol Sci. 2021 Apr 11;22(8):
pubmed: 33920443
Microorganisms. 2022 Jan 19;10(2):
pubmed: 35208666
Chem Rev. 2018 Feb 28;118(4):1917-1950
pubmed: 29384376
Methods Mol Biol. 2017;1494:239-252
pubmed: 27718198
Environ Microbiol. 2020 Jul;22(7):2457-2460
pubmed: 32363801
ISME J. 2022 Feb;16(2):500-510
pubmed: 34433898
Front Microbiol. 2017 Jun 13;8:1040
pubmed: 28659878
Front Microbiol. 2022 Dec 01;13:945972
pubmed: 36532464
Nat Commun. 2016 Apr 14;7:11220
pubmed: 27075392
Infect Immun. 2019 Oct 18;87(11):
pubmed: 31481407
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9302-9310
pubmed: 32245809

Auteurs

Beatrice Marinacci (B)

Department of Pharmacy, University "G. d'Annunzio", Chieti-Pescara, 66100 Chieti, Italy.
Department of Innovative Technologies in Medicine & Dentistry, University of Chieti-Pescara, 66100 Chieti, Italy.

Paweł Krzyżek (P)

Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.

Benedetta Pellegrini (B)

Department of Pharmacy, University "G. d'Annunzio", Chieti-Pescara, 66100 Chieti, Italy.

Gabriele Turacchio (G)

Institute of Endocrinology and Experimental Oncology "Gaetano Salvatore" (IEOS), National Research Council, 80131 Naples, Italy.
Institute of Translational Pharmacology (IFT), National Research Council, 67100 L'Aquila, Italy.

Rossella Grande (R)

Department of Pharmacy, University "G. d'Annunzio", Chieti-Pescara, 66100 Chieti, Italy.
Center for Advanced Studies and Technology (CAST), University "G. d'Annunzio", Chieti-Pescara, 66100 Chieti, Italy.

Classifications MeSH